Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 11, 2023
Accession Number:
0001140361-23-047719
Submission Type:
POS AM
CIK:
0001621443
Company Name:
Zynerba Pharmaceuticals, Inc.
File Number:
333-264966